Description:
Mabura is a biologic therapy based on adalimumab, a fully human monoclonal antibody that targets and neutralizes tumor necrosis factor-alpha (TNF-α). It is used to treat a wide range of autoimmune disorders, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis.
Mabura provides long-term control of inflammation, reduces joint damage, and improves physical function. It is available as a prefilled pen for subcutaneous self-administration and is widely recognized for its reliability and clinical impact across specialties.
Share your experience with our medical product. Write a review!
01 Jun 2026
Salt, Stress, and Sedentary Life: The Three Big Triggers of Hypertension
Every two seconds, somewhere in the world, a person suffers a heart attack or stroke linked to uncontrolled blood pressure.
25 Apr 2026
World Liver Day 2026: Signs, Causes & How to Protect Your Liver Naturally
The liver is one of the most vital organs in the human body, responsible for detoxification, metabolism, and nutrient storage. Yet, liver health is often overlooked until symptoms become serious.
15 Apr 2026
World Health Day 2026: Small Health Habits That Prevent Big Diseases
Every year, World Health Day reminds us of something very simple yet powerful-our health deserves attention every single day, not only when something goes wrong. World Health Day 2026 is a good moment
25 Mar 2026
Transdermal Patches 2026: Latest Trends, Benefits & How They’re Revolutionizing Pain & Nicotine Relief
Transdermal patches are advanced drug delivery systems that deliver medication through the skin directly into the bloodstream. In 2026, new health technology trends are making transdermal patches more
